pyrroles has been researched along with uric acid in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (11.54) | 18.7374 |
| 1990's | 3 (5.77) | 18.2507 |
| 2000's | 16 (30.77) | 29.6817 |
| 2010's | 23 (44.23) | 24.3611 |
| 2020's | 4 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Pinto, B; Rocha, E | 2 |
| Pinto, B; Rocha, E; Ruiz-Marcellán, FJ | 1 |
| Marcellan, FJ; Pinto, B; Rocha, E | 1 |
| Becker, BF; Gerlach, E; Leipert, B; Raschke, P; Reinholz, N | 1 |
| Gibson, SL; Goldberg, A; Mackenzie, JC | 1 |
| Gaismayer, K; Petera, P; Tausch, G | 1 |
| Krawczyñski vel Krawczyk, T; Lewenstam, M; Moszczynska, A; Trojanowicz, M | 1 |
| Bateman, ME; Byrnes, P; Firth, JC; Marais, AD; Martens, C; Mountney, J | 1 |
| Bhat, VB; Madyastha, KM | 1 |
| Decaux, G | 1 |
| Elisaf, M; Kakafika, A; Tsimihodimos, V | 1 |
| Elisaf, M; Kakafika, A; Liamis, G; Mikhailidis, D | 1 |
| Chasiotis, G; Elisaf, MS; Kakafika, A; Milionis, HJ; Papakostas, J; Seferiadis, K | 1 |
| Athyros, VG; Bouloukos, VI; Elisaf, M; Mikhailidis, DP; Milionis, HJ; Papageorgiou, AA; Pehlivanidis, AN; Symeonidis, AN | 1 |
| Athyros, VG; Bairaktari, ET; Elisaf, MS; Kakafika, AI; Milionis, HJ; Seferiadis, KI; Tsouli, SG | 1 |
| Jiang, X; Lin, X | 1 |
| Daskalopoulou, SS; Elisaf, M; Mikhailidis, DP; Tzovaras, V | 1 |
| Arslan, F; Cete, S; Yaşar, A | 1 |
| Athyros, VG; Elisaf, M; Ganotakis, ES; Kakafika, AI; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP; Papageorgiou, AA; Tziomalos, K | 1 |
| Li, Y; Lin, X; Wang, L; Wang, P | 1 |
| Li, J; Lin, XQ | 1 |
| Chen, YD; Ge, CJ; Hu, SJ; Ji, Y; Lu, SZ; Wu, XF | 1 |
| Jia, Z; Li, Y; Mahaney, JE; Misra, BR; Misra, HP; Zhu, H | 1 |
| Todd, DJ | 1 |
| Dursun, Z; Ulubay, S | 1 |
| Atta, NF; El-Kady, MF; Galal, A | 1 |
| López-Cuenca, A; Marín, F; Roldán, V | 1 |
| Fujimori, S; Kaneko, K; Ogata, N; Oka, Y | 1 |
| Alexandrides, T; Athyros, VG; Bacharoudis, G; Ganotakis, ES; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP; Nicolaou, V; Paletas, K; Tziomalos, K | 1 |
| Elisaf, M; Katsiki, N | 1 |
| Chen, H; Kannan, P; Kim, DH; Si, P | 1 |
| Arslan, F; Çete, S; Dolmaci, N; Yaşar, A | 1 |
| Takagi, H; Umemoto, T | 1 |
| Ike, A; Iwata, A; Kawamura, A; Miura, S; Nishikawa, H; Saku, K; Sugihara, M; Tanaka, T | 1 |
| Qian, T; Shen, J; Wu, S | 1 |
| Banach, M; Bielecka-Dabrowa, A; Mikhailidis, DP; Rizzo, M; Rysz, J; von Haehling, S | 1 |
| An, T; Hayashi, H; Kikkawa, A; Kose, E; Matsumoto, Y | 1 |
| Elisaf, M; Kei, A; Liberopoulos, E; Tellis, C; Tselepis, A | 1 |
| Alemán, C; Armelin, E; Casanovas, J; Fabregat, G; Redondo, E | 1 |
| Cong, H; Fu, N; Jin, D; Li, H; Li, X; Ma, H; Wang, Y | 1 |
| Cesarino, I; Galesco, HV; Machado, SA | 1 |
| Chngrian, GV; Mysyshin, MB; Semegen-Bodak, KV; Slaba, NA; Solomenchuk, TN | 1 |
| Geng, Z; Liu, F; Mao, C; Ni, Y; Shen, X; Song, Y; Sun, C; Wang, D; Xu, W; Zhang, M | 1 |
| Ghanbari, Kh; Hajheidari, N | 1 |
| Castillo-Ortega, MM; Cruz-Silva, R; del Castillo-Castro, T; Evans-Villegas, AG; Grijalva-Bustamante, GA; Huerta, F; Morallón, E | 1 |
| Ericsson, H; Fuhr, R; Gan, LM; Heijer, M; Kjaer, M; Lagerström-Fermér, M; Lindstedt, EL; Michaëlsson, E; Nelander, K; Whatling, C | 1 |
| Baldini, E; Bernardini, G; Jacomelli, G; Micheli, V; Mugnaini, C; Santucci, A | 1 |
| Sha, JQ; Sheng, N; Wang, DH; Wang, YY; Yin, L; Zhang, GG; Zhang, HF | 1 |
| Ashizawa, N; Iwanaga, T; Kobashi, S; Matsumoto, K; Uda, J | 1 |
| Luo, X; Wang, L; Wang, Y; Wu, X; Xue, H; Zhang, P | 1 |
| Heryanto, R; Khalil, M; Khoerunnisa, F; Marken, F; Nisa, U; Putra, BR; Ridhova, A; Thaha, YN; Wahyuni, WT | 1 |
2 review(s) available for pyrroles and uric acid
| Article | Year |
|---|---|
Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Fenofibrate; Heptanoic Acids; Humans; Losartan; Pyrroles; Uric Acid | 2005 |
Atorvastatin therapy reduces serum uric acid levels: a meta-analysis of randomized controlled trials.
Topics: Atorvastatin; Biomarkers; Cardiovascular Diseases; Heptanoic Acids; Humans; Pyrroles; Randomized Controlled Trials as Topic; Treatment Outcome; Uric Acid | 2012 |
11 trial(s) available for pyrroles and uric acid
| Article | Year |
|---|---|
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
Topics: Adult; Anticholesteremic Agents; Apolipoproteins A; Apolipoproteins B; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Enzyme Inhibitors; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Middle Aged; Pyrroles; Uric Acid | 1997 |
Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Diuresis; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Potassium; Pyrroles; Sodium; Urea; Uric Acid; Water; Water-Electrolyte Balance | 2001 |
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
Topics: Analysis of Variance; Atorvastatin; Blood Glucose; Female; Fenofibrate; Heptanoic Acids; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Simvastatin; Uric Acid | 2003 |
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
Topics: Atorvastatin; Female; Heptanoic Acids; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipids; Logistic Models; Male; Middle Aged; Pyrroles; Simvastatin; Uric Acid | 2004 |
Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atorvastatin; Blood Pressure; C-Reactive Protein; Drug Synergism; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Lipids; Male; Middle Aged; Pyrroles; Time Factors; Treatment Outcome; Uric Acid; Ventricular Remodeling | 2008 |
Hypouricemic effect of statins: another pleiotropic benefit?
Topics: Atorvastatin; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperuricemia; Lipids; Pyrroles; Time Factors; Treatment Outcome; Uric Acid | 2010 |
Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Dyslipidemias; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Pyrroles; Quinolines; Rosuvastatin Calcium; Sulfonamides; Uric Acid | 2010 |
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study.
Topics: Aged; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Disease-Free Survival; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Pyrroles; Uric Acid | 2011 |
The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Cardiomyopathy, Dilated; Cytokines; Female; Follow-Up Studies; Heptanoic Acids; Hospitalization; Humans; Inflammation; Male; Middle Aged; Pyrroles; Uric Acid; Ventricular Function, Left | 2013 |
Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
Topics: Aged; Apolipoprotein B-100; Atorvastatin; Bilirubin; Biomarkers; Dinoprost; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Fluorobenzenes; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Lipoproteins, LDL; Male; Middle Aged; Niacin; Oxidative Stress; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Uric Acid | 2014 |
Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers.
Topics: Administration, Oral; Adult; Area Under Curve; Cardiovascular Diseases; Drug Administration Schedule; Enzyme Inhibitors; Half-Life; Healthy Volunteers; Humans; Male; Middle Aged; Peroxidase; Placebos; Pyrimidines; Pyrroles; Single-Blind Method; Uric Acid; Young Adult | 2019 |
39 other study(ies) available for pyrroles and uric acid
| Article | Year |
|---|---|
Interaction of uricine with uric acid and its effect on uric acid precipitation.
Topics: Binding Sites; Chemical Phenomena; Chemical Precipitation; Chemistry; Hydrogen-Ion Concentration; Pigments, Biological; Purines; Pyrroles; Uric Acid | 1977 |
Isolation and characterization of uricine from uric acid stones.
Topics: Chemical Phenomena; Chemistry; Color; Hydrogen-Ion Concentration; Mass Spectrometry; Molecular Weight; Pigments, Biological; Pyrroles; Solubility; Uric Acid; Urinary Calculi | 1976 |
Uricine-uric acid interactions.
Topics: Chemical Precipitation; Hydrogen-Ion Concentration; Pigments, Biological; Pyrroles; Solubility; Ultracentrifugation; Uric Acid | 1977 |
Urinary excretion of uricine.
Topics: Bilirubin; Calcium; Chemical Precipitation; Gout; Humans; Kidney; Pigments, Biological; Pyrroles; Uric Acid; Urinary Calculi | 1977 |
[Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bridged Bicyclo Compounds; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Enalapril; Guinea Pigs; Hemodynamics; Hydroxides; Hydroxyl Radical; Luminescent Measurements; Myocardial Reperfusion Injury; Pyrroles; Ramipril; Sulfhydryl Reagents; Uric Acid | 1991 |
The diagnosis of industrial lead poisoning.
Topics: Adult; Blood Cell Count; Blood Pressure Determination; Environmental Exposure; Hematocrit; Humans; Kidney Diseases; Lead; Lead Poisoning; Levulinic Acids; Male; Porphyrins; Pyrroles; Reticulocytes; Urea; Uric Acid | 1968 |
[Treatment of acute gout attacks with tolmetin (author's transl)].
Topics: Acute Disease; Adult; Aged; Analgesia; Gout; Humans; Male; Middle Aged; Pyrroles; Tolmetin; Uric Acid | 1982 |
Lactate solid-state biosensor with multilayer of electrodeposited polymers for flow-injection clinical analysis.
Topics: Acetaminophen; Ascorbic Acid; Biosensing Techniques; Chemistry, Clinical; Electrodes; Enzymes, Immobilized; Flavonoids; Humans; Lactates; Mixed Function Oxygenases; Phenols; Platinum; Polymers; Polyphenols; Pyrroles; Uric Acid | 1996 |
C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro.
Topics: Animals; Antioxidants; Bacterial Proteins; Borohydrides; Carbon Tetrachloride; Carotenoids; Free Radical Scavengers; Free Radicals; Hydroxyl Radical; Inhibitory Concentration 50; Kinetics; Lipid Peroxidation; Mass Spectrometry; Microsomes, Liver; Oxidation-Reduction; Peroxides; Phycobilins; Phycocyanin; Pyrroles; Rats; Spectrophotometry; Spirulina; Tetrapyrroles; Uric Acid | 2000 |
Effect of atorvastatin on serum uric acid levels.
Topics: Anticholesteremic Agents; Atorvastatin; Heptanoic Acids; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pyrroles; Uric Acid | 2001 |
Effect of atorvastatin on serum creatinine levels.
Topics: Anticholesteremic Agents; Atorvastatin; Creatinine; Heptanoic Acids; Humans; Pyrroles; Retrospective Studies; Uric Acid | 2001 |
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
Topics: Aged; Atorvastatin; Coronary Disease; Creatinine; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Proportional Hazards Models; Pyrroles; Uric Acid | 2004 |
Immobilization of DNA on carbon fiber microelectrodes by using overoxidized polypyrrole template for selective detection of dopamine and epinephrine in the presence of high concentrations of ascorbic acid and uric acid.
Topics: Ascorbic Acid; Biosensing Techniques; Carbon; Carbon Fiber; DNA; Dopamine; Epinephrine; Humans; Microelectrodes; Polymers; Pyrroles; Uric Acid | 2005 |
An amperometric biosensor for uric acid determination prepared from uricase immobilized in polypyrrole film.
Topics: Acetaminophen; Ascorbic Acid; Biosensing Techniques; Body Fluids; Electrochemistry; Enzyme Stability; Enzymes, Immobilized; Humans; Hydrogen-Ion Concentration; Methionine; Polymers; Pyrroles; Reproducibility of Results; Temperature; Urate Oxidase; Uric Acid | 2006 |
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluati
Topics: Aged; Atorvastatin; Coronary Disease; Cost-Benefit Analysis; Creatinine; Female; Glomerular Filtration Rate; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Metabolic Syndrome; Middle Aged; Pyrroles; Uric Acid | 2007 |
Overoxidized polypyrrole film directed single-walled carbon nanotubes immobilization on glassy carbon electrode and its sensing applications.
Topics: Ascorbic Acid; Biosensing Techniques; Catalysis; Dopamine; Electrochemistry; Electrodes; Nanotubes, Carbon; Oxidation-Reduction; Polymers; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Uric Acid | 2007 |
Electrodeposition of gold nanoclusters on overoxidized polypyrrole film modified glassy carbon electrode and its application for the simultaneous determination of epinephrine and uric acid under coexistence of ascorbic acid.
Topics: Animals; Ascorbic Acid; Carbon; Cattle; Electrodes; Electroplating; Epinephrine; Gold; Humans; Metal Nanoparticles; Oxidants; Polymers; Pyrroles; Uric Acid | 2007 |
EPR studies on the superoxide-scavenging capacity of the nutraceutical resveratrol.
Topics: Dietary Supplements; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Oxygen Consumption; Pyrroles; Resveratrol; Spin Labels; Stilbenes; Superoxides; Uric Acid; Xanthine; Xanthine Oxidase | 2008 |
Serum uric acid level reduction, cardiovascular outcome, and mortality: comment on the article by Ioachimescu et al.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Cardiovascular Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Predictive Value of Tests; Pyrroles; Treatment Outcome; Uric Acid | 2008 |
Cu nanoparticles incorporated polypyrrole modified GCE for sensitive simultaneous determination of dopamine and uric acid.
Topics: Ascorbic Acid; Carbon; Catalysis; Copper; Dopamine; Electrochemistry; Electrodes; Glass; Humans; Metal Nanoparticles; Microscopy, Atomic Force; Oxidation-Reduction; Polymers; Pyrroles; Time Factors; Uric Acid | 2010 |
Simultaneous determination of catecholamines, uric acid and ascorbic acid at physiological levels using poly(N-methylpyrrole)/Pd-nanoclusters sensor.
Topics: Ascorbic Acid; Biosensing Techniques; Catalysis; Catecholamines; Electrochemical Techniques; Electrodes; Electroplating; Humans; Metal Nanoparticles; Oxidation-Reduction; Palladium; Polymers; Pyrroles; Uric Acid | 2010 |
Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease.
Topics: Atorvastatin; Cholesterol, LDL; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Metabolic Syndrome; Pyrroles; Uric Acid | 2011 |
Selective and sensitive determination of dopamine by composites of polypyrrole and graphene modified electrodes.
Topics: Ascorbic Acid; Dopamine; Electrochemical Techniques; Electrodes; Graphite; Humans; Oxidation-Reduction; Polymers; Pyrroles; Uric Acid | 2011 |
An amperometric biosensor for fish freshness detection from xanthine oxidase immobilized in polypyrrole-polyvinylsulphonate film.
Topics: Animals; Biocatalysis; Biosensing Techniques; Electrochemistry; Electrodes; Enzymes, Immobilized; Fishes; Food Analysis; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hypoxanthine; Methylene Blue; Polymers; Polyvinyls; Pyrroles; Reproducibility of Results; Sulfonic Acids; Temperature; Uric Acid; Xanthine; Xanthine Oxidase | 2012 |
Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
Topics: Aged; Angina, Stable; Atorvastatin; Biomarkers; C-Reactive Protein; Case-Control Studies; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Down-Regulation; Female; Fibrosis; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Lipids; Male; Middle Aged; Plaque, Atherosclerotic; Predictive Value of Tests; Pyrroles; Serum Amyloid P-Component; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Uric Acid | 2012 |
Facilely prepared polypyrrole-reduced graphite oxide core-shell microspheres with high dispersibility for electrochemical detection of dopamine.
Topics: Ascorbic Acid; Dopamine; Electrochemical Techniques; Graphite; Microspheres; Oxidation-Reduction; Oxides; Polymers; Pyrroles; Uric Acid | 2013 |
Effects on serum uric acid by difference of the renal protective effects with atorvastatin and rosuvastatin in chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Female; Fluorobenzenes; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hyperuricemia; Kidney; Male; Middle Aged; Pyrimidines; Pyrroles; Renal Insufficiency, Chronic; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides; Uric Acid | 2014 |
A rational design for the selective detection of dopamine using conducting polymers.
Topics: Ascorbic Acid; Bridged Bicyclo Compounds, Heterocyclic; Dopamine; Electric Conductivity; Electrochemical Techniques; Gold; Metal Nanoparticles; Models, Molecular; Oxidation-Reduction; Polymerization; Polymers; Pyrroles; Uric Acid | 2014 |
Atorvastatin combining with probucol: a new way to reduce serum uric acid level during perioperative period of interventional procedure.
Topics: Acute Kidney Injury; Aged; Antioxidants; Atorvastatin; Biomarkers; Contrast Media; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Function Tests; Male; Middle Aged; Perioperative Period; Probucol; Prospective Studies; Pyrroles; Risk Factors; Uric Acid | 2014 |
Determination of serotonin on platinum electrode modified with carbon nanotubes/polypyrrole/silver nanoparticles nanohybrid.
Topics: Ascorbic Acid; Electrochemical Techniques; Electrodes; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Nanostructures; Nanotubes, Carbon; Oxidation-Reduction; Polymers; Pyrroles; Serotonin; Silver; Uric Acid | 2014 |
[Proaterogenic metabolic disorders in patients with chronic kidney disease nondiabetic origin: possibility of statin therapy].
Topics: Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Blood Pressure; Cardiotonic Agents; Disease Progression; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Heptanoic Acids; Humans; Lipid Metabolism; Male; Metabolic Diseases; Middle Aged; Prognosis; Pyrroles; Renal Insufficiency, Chronic; Treatment Outcome; Uric Acid | 2014 |
Novel L-lactic acid biosensors based on conducting polypyrrole-block copolymer nanoparticles.
Topics: Animals; Ascorbic Acid; Biosensing Techniques; Circular Dichroism; Cysteine; Electrochemistry; Electrodes; Enzymes, Immobilized; Glucose; Lactic Acid; Limit of Detection; Microscopy, Electron, Transmission; Mixed Function Oxygenases; Muscle, Skeletal; Nanoparticles; Polymers; Pyrroles; Swine; Uric Acid | 2015 |
ZnO-CuxO/polypyrrole nanocomposite modified electrode for simultaneous determination of ascorbic acid, dopamine, and uric acid.
Topics: Ascorbic Acid; Copper; Dopamine; Electrochemistry; Electrodes; Injections; Models, Molecular; Molecular Conformation; Nanocomposites; Polymers; Pyrroles; Time Factors; Uric Acid; Zinc Oxide | 2015 |
Enzyme mediated synthesis of polypyrrole in the presence of chondroitin sulfate and redox mediators of natural origin.
Topics: Acetophenones; Benzaldehydes; Catalysis; Chondroitin Sulfates; Electric Conductivity; Electrochemical Techniques; Electrodes; Glycine max; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Oxidation-Reduction; Peroxidases; Photoelectron Spectroscopy; Polymerization; Polymers; Pyrroles; Spectroscopy, Fourier Transform Infrared; Uric Acid | 2016 |
Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.
Topics: Allopurinol; Cells, Cultured; Enzyme Inhibitors; Humans; Hyperuricemia; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Lesch-Nyhan Syndrome; Purine-Nucleoside Phosphorylase; Purines; Pyrimidinones; Pyrroles; Reproducibility of Results; Uric Acid; Xanthine | 2019 |
Development of a Uricase-Free Colorimetric Biosensor for Uric Acid Based on PPy-Coated Polyoxometalate-Encapsulated Fourfold Helical Metal-Organic Frameworks.
Topics: Biosensing Techniques; Colorimetry; Hydrogen Peroxide; Metal-Organic Frameworks; Polymers; Pyrroles; Tungsten Compounds; Urate Oxidase; Uric Acid | 2020 |
Novel monocyclic amide-linked phenol derivatives without mitochondrial toxicity have potent uric acid-lowering activity.
Topics: Amides; Animals; Benzbromarone; Drug Evaluation, Preclinical; Glucose Transport Proteins, Facilitative; Humans; Mitochondria; Phenol; Pyrroles; Sapajus apella; Signal Transduction; Structure-Activity Relationship; Uric Acid; Uricosuric Agents | 2021 |
Wearable transdermal colorimetric microneedle patch for Uric acid monitoring based on peroxidase-like polypyrrole nanoparticles.
Topics: Colorimetry; Coloring Agents; Humans; Hydrogen Peroxide; Nanoparticles; Peroxidase; Polymers; Pyrroles; Uric Acid; Wearable Electronic Devices | 2022 |
Selective non-enzymatic uric acid sensing in the presence of dopamine: electropolymerized poly-pyrrole modified with a reduced graphene oxide/PEDOT:PSS composite.
Topics: Ascorbic Acid; Carbon; Dopamine; Electrochemical Techniques; Electrodes; Graphite; Humans; Limit of Detection; Pyrroles; Reproducibility of Results; Uric Acid | 2022 |